Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.8789423604060562e-78,187.6487486398259,33583.67072137389,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.651455955837439e-76,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.012678396081746e-53,55.17751479289941,6672.84752870573,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.3324407610646905e-51,0,0,60
3,Oxidative phosphorylation WP623,6.889746033990602e-33,59.97857142857143,4441.729531947504,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",8.12990032010891e-31,0,0,36
4,Nonalcoholic fatty liver disease WP4396,3.5234480780076207e-29,11.588583306683722,759.2321496948705,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",3.1182515490367444e-27,0,0,52
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.829989798550621e-27,57.95548654244306,3568.057760178884,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.2956327773738396e-25,0,0,30
6,Mitochondrial CIV Assembly WP4922,5.184773364858939e-18,45.89344262295082,1826.5959855318401,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14', 'COX20']",3.059016285266774e-16,0,0,20
7,Mitochondrial complex III assembly WP4921,2.734064930123085e-08,34.04255319148936,592.8473619336852,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.3826556932336744e-06,0,0,9
8,Cellular Proteostasis WP4918,2.9210917753697195e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",1.2925831106011009e-05,0,0,6
9,mRNA Processing WP411,1.0396947559460009e-05,4.338581146744412,49.780872696932576,"['SF3B5', 'DHX8', 'NCBP2', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.00040894660400542704,0,0,16
10,Nucleotide Excision Repair WP4753,0.00018896224091741618,5.6661600810536985,48.581448849617864,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.006689263328476532,0,0,9
11,DNA Mismatch Repair WP531,0.0004942009053693505,8.481060606060606,64.56265424315188,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.015904283681886372,0,0,6
12,Translation Factors WP107,0.000569504153983815,4.198031703102697,31.362422177078006,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF1AY', 'EIF3I', 'EIF4H', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.016800372542522545,0,0,10
13,Pyrimidine metabolism WP4022,0.0009490615205588973,3.3200475907198097,23.10765385648385,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.025789436785676433,0,0,12
14,Cholesterol Biosynthesis Pathway WP197,0.001092772745155781,9.415573494786411,64.20514412977923,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.025789436785676433,0,0,5
15,Computational Model of Aerobic Glycolysis WP4629,0.001092772745155781,9.415573494786411,64.20514412977923,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.025789436785676433,0,0,5
16,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0017480453440026685,8.06977079429148,51.23704920098952,"['EIF3I', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.03867550323605904,0,0,5
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.003360707114332084,1.71296875,9.756391452745577,"['RPL5', 'SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'CYCS', 'RPL27', 'RPL26', 'EIF3F', 'CALR', 'ALDOA', 'EIF3D', 'PTMA']",0.06998178343962104,0,0,36
18,Proteasome Degradation WP183,0.004208906937243428,3.286204529855868,17.977353748606323,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMA2', 'PSME1', 'PSMB10', 'PSMA7']",0.08277516976578742,0,0,9
19,Ciliary landscape WP4352,0.004664725327696842,2.047703441146064,10.991511668461385,"['NUDC', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'EXOSC4', 'RAB14', 'MFAP1', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.08691119821077274,0,0,20
20,Synaptic Vesicle Pathway WP2267,0.0061828417824700155,3.351626930574299,17.04629841274201,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.10943629954971927,0,0,8
21,Glycolysis and Gluconeogenesis WP534,0.00739334275667996,3.231636784268363,15.85820824238319,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'ALDOA', 'PFKM']",0.12463063504117647,0,0,8
22,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.008992858637015667,11.278952668680766,53.13880605805987,"['ELOB', 'ELOC', 'RBX1']",0.1384118242392846,0,0,3
23,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.008992858637015667,11.278952668680766,53.13880605805987,"['IDI1', 'HMGCS1', 'PMVK']",0.1384118242392846,0,0,3
24,Photodynamic therapy-induced unfolded protein response WP3613,0.012526479495220457,4.342932546767058,19.021655930197443,"['NARS', 'XBP1', 'DDIT3', 'CALR', 'HSP90B1']",0.18476557255450174,0,0,5
25,Dual hijack model of Vif in HIV infection WP3300,0.014789012100075563,8.458459214501511,35.64285429373976,"['ELOB', 'ELOC', 'RBX1']",0.20941241133706998,0,0,3
26,Cori Cycle WP1946,0.017370640136892306,5.015232974910394,20.32660808087421,"['LDHA', 'TPI1', 'PGK1', 'ALDOA']",0.23650794647922602,0,0,4
27,Mevalonate pathway WP3963,0.018894122918896642,22.53923541247485,89.45606974349302,"['HMGCS1', 'PMVK']",0.2403108554537653,0,0,2
28,DNA Repair Pathways Full Network WP4946,0.01900763828447861,2.2229332849891223,8.809294248919382,"['POLE4', 'POLD4', 'RFC3', 'NEIL2', 'CENPX', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.2403108554537653,0,0,11
29,Selenium Micronutrient Network WP15,0.020103352301041943,2.3086475969698226,9.019583028260373,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.24539954188168442,0,0,10
30,Ferroptosis WP4313,0.023159330440241873,3.080165289256198,11.59792358672094,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.26102213159401205,0,0,6
31,Base Excision Repair WP4752,0.024269203322161755,3.5276866801210898,13.117869022583083,"['POLE4', 'POLD4', 'NEIL2', 'POLD2', 'POLE3']",0.26102213159401205,0,0,5
32,Eukaryotic Transcription Initiation WP405,0.024269203322161755,3.5276866801210898,13.117869022583083,"['GTF2A2', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.26102213159401205,0,0,5
33,Melanoma WP4685,0.024332571589272312,2.5116959064327484,9.333309858756845,"['CCND1', 'BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.26102213159401205,0,0,8
34,Androgen receptor signaling pathway WP138,0.029484702020791165,2.2609929078014184,7.967476111746191,"['CCND1', 'SUMO1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.30698777986353154,0,0,9
35,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.03178304056326557,2.822979797979798,9.735956094925932,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.32146275312560035,0,0,6
36,Amyotrophic lateral sclerosis (ALS) WP2447,0.035068505861355126,3.135160892476735,10.504205518831956,"['TOMM40', 'BAD', 'NEFL', 'BAX', 'SOD1']",0.34203947938840823,0,0,5
37,Gastric acid production WP2596,0.03574988908861894,11.268611670020121,37.53809060911464,"['CCK', 'VIP']",0.34203947938840823,0,0,2
38,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.056392407353922584,7.511737089201878,21.599404701782138,"['COX8A', 'COX5A']",0.49907280508221485,0,0,2
39,Trans-sulfuration pathway WP2333,0.056392407353922584,7.511737089201878,21.599404701782138,"['AHCY', 'GOT1']",0.49907280508221485,0,0,2
40,Peroxiredoxin 2 induced ovarian failure WP4873,0.056392407353922584,7.511737089201878,21.599404701782138,"['STAR', 'BAX']",0.49907280508221485,0,0,2
41,7q11.23 copy number variation syndrome WP4932,0.05811907918041209,1.9554009819967266,5.5636267084303626,"['ATP5PB', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.5018086348747776,0,0,9
42,Nanomaterial induced apoptosis WP2507,0.0684271440542484,3.7576367908694195,10.077928101992832,"['ENDOG', 'BAX', 'CYCS']",0.5767430713143794,0,0,3
43,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0733539488958595,2.4525073487474223,6.407074747419499,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.6038906490496341,0,0,5
44,TCA cycle in senescence WP5050,0.08009221347243443,5.633299798792756,14.221697076543384,"['PDHA1', 'GOT1']",0.6307535067681246,0,0,2
45,Mitochondrial CII Assembly WP4920,0.08164579219489321,inf,inf,['SDHAF1'],0.6307535067681246,0,0,1
46,DNA Replication WP466,0.08295971126826233,2.3501093171880254,5.850362593512869,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.6307535067681246,0,0,5
47,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.08374410965565496,3.381570996978852,8.386260374007149,"['LDHA', 'PDHA1', 'RPS6']",0.6307535067681246,0,0,3
48,Type 2 papillary renal cell carcinoma WP4241,0.09947148910016608,2.505600358422939,5.782635522780578,"['SETD2', 'ELOB', 'ELOC', 'RBX1']",0.7336022321137249,0,0,4
49,HIF1A and PPARG regulation of glycolysis WP2456,0.1062135194282389,4.506237424547284,10.104353646358243,"['LDHA', 'TPI1']",0.7673384872978891,0,0,2
50,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.11303001944182768,2.3735144312393888,5.17450317115365,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.80025253764814,0,0,4
51,Copper homeostasis WP3286,0.11548428518982799,2.0884254587584556,4.508118670529325,"['CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.8015968030823355,0,0,5
52,TP53 network WP1742,0.1370707882001725,2.6005112712061353,5.167886267144054,"['SUMO1', 'GADD45A', 'BAX']",0.9331357504396358,0,0,3
53,Sleep regulation WP3591,0.1423863404964724,2.1470814132104454,4.1851151553008705,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9510332931273816,0,0,4
54,miRNA Biogenesis WP2338,0.1566318075479148,11.258291457286433,20.871266960040128,['RAN'],0.9815068351350275,0,0,1
55,Non-small cell lung cancer WP4255,0.1576356662413486,1.7348873348873348,3.2051502548570703,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9815068351350275,0,0,6
56,Alzheimer's disease WP2059,0.1588588605527873,1.6448643410852712,3.0261213090301498,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9815068351350275,0,0,7
57,Cysteine and methionine catabolism WP4504,0.16358447252250458,3.218166139695315,5.826250913214139,"['AHCY', 'GOT1']",0.9815068351350275,0,0,2
58,Glycolysis in senescence WP5049,0.16358447252250458,3.218166139695315,5.826250913214139,"['LDHA', 'PGK1']",0.9815068351350275,0,0,2
59,Homologous recombination WP186,0.16358447252250458,3.218166139695315,5.826250913214139,"['POLD4', 'POLD2']",0.9815068351350275,0,0,2
60,NO/cGMP/PKG mediated Neuroprotection WP4008,0.17437227233508856,1.9600280504908836,3.4233120192842494,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9999777920878447,0,0,4
61,Unfolded protein response WP4925,0.17752515308999053,2.25337361530715,3.895278464646044,"['XBP1', 'DDIT3', 'EIF2S1']",0.9999777920878447,0,0,3
62,Metabolic reprogramming in colon cancer WP4290,0.19120866288057736,1.8781922043010753,3.1072623472294816,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9999777920878447,0,0,4
63,Fatty acid transporters WP5061,0.19394249294278523,2.8156438631790746,4.618201021718718,"['FABP3', 'FABP6']",0.9999777920878447,0,0,2
64,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.1947039902163361,1.6105339105339105,2.6352761693358073,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9999777920878447,0,0,6
65,Canonical and non-canonical Notch signaling WP3845,0.19884505632396202,2.1123489425981874,3.4119280495980333,"['RRAS', 'MFAP1', 'DLL3']",0.9999777920878447,0,0,3
66,Gastric Cancer Network 2 WP2363,0.2207305473149807,1.987915407854985,3.0033675748820614,"['RFC3', 'S100A6', 'COL9A3']",0.9999777920878447,0,0,3
67,Serotonin and anxiety WP3947,0.22492289166334314,2.502570981444221,3.7338299963266155,"['POMC', 'CRH']",0.9999777920878447,0,0,2
68,Galanin receptor pathway WP4970,0.22492289166334314,2.502570981444221,3.7338299963266155,"['POMC', 'VAMP2']",0.9999777920878447,0,0,2
69,RalA downstream regulated genes WP2290,0.22492289166334314,2.502570981444221,3.7338299963266155,"['RAC3', 'HRAS']",0.9999777920878447,0,0,2
70,Proximal tubule transport WP4917,0.22505646710680094,1.6099178319158138,2.4010378029807242,"['ATP6V1G1', 'ATP6V1E1', 'SLC6A20', 'ATP6V1D', 'ATP6V1F']",0.9999777920878447,0,0,5
71,MED and Pseudoachondroplasia genes WP4789,0.2255006789112686,5.628643216080402,8.383481938110542,['COL9A3'],0.9999777920878447,0,0,1
72,Myometrial relaxation and contraction pathways WP289,0.22761557740038532,1.3340974837618034,1.9745938662838673,"['PKIB', 'GNG3', 'YWHAQ', 'GSTO1', 'CRH', 'CALM3', 'ADCY2', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9999777920878447,0,0,11
73,Endometrial cancer WP4155,0.24052135651638276,1.5650577418993161,2.230123383991716,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'HRAS']",0.9999777920878447,0,0,5
74,GABA receptor Signaling WP4159,0.2430650865942824,1.8773078214165828,2.6553130403716865,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9999777920878447,0,0,3
75,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2562220439163312,2.252112676056338,3.0667262695454145,"['BAD', 'BAX']",0.9999777920878447,0,0,2
76,Nucleotide metabolism WP404,0.2562220439163312,2.252112676056338,3.0667262695454145,"['NME2', 'OAZ1']",0.9999777920878447,0,0,2
77,IL-18 signaling pathway WP4754,0.2563137266284747,1.2279328057753713,1.671650119658165,"['NRN1', 'TOMM40', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'ITM2C']",0.9999777920878447,0,0,16
78,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.27686932180499024,1.408459595959596,1.8087573999023923,"['CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999777920878447,0,0,6
79,MET in type 1 papillary renal cell carcinoma WP4205,0.28145570044204626,1.5536707452725251,1.9697130290594917,"['BAD', 'RPL11', 'HRAS', 'PAK4']",0.9999777920878447,0,0,4
80,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.2875816680967906,2.047192244375343,2.5513100511381315,"['RRAS', 'HRAS']",0.9999777920878447,0,0,2
81,Intraflagellar transport proteins binding to dynein WP4532,0.2875816680967906,2.047192244375343,2.5513100511381315,"['IFT22', 'DYNLL1']",0.9999777920878447,0,0,2
82,Acetylcholine Synthesis WP528,0.28875094884486374,3.7520938023450587,4.660816143523485,['PDHA1'],0.9999777920878447,0,0,1
83,Bladder cancer WP2828,0.31168562073565464,1.6086893972090346,1.8753461136714424,"['CCND1', 'DAPK1', 'HRAS']",0.9999777920878447,0,0,3
84,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.31168562073565464,1.6086893972090346,1.8753461136714424,"['STAR', 'CALM3', 'CALM2']",0.9999777920878447,0,0,3
85,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.31878345713095496,1.8764252179745138,2.145210416673433,"['CD63', 'SOD1']",0.9999777920878447,0,0,2
86,Methionine De Novo and Salvage Pathway WP3580,0.31878345713095496,1.8764252179745138,2.145210416673433,"['AHCY', 'TXN']",0.9999777920878447,0,0,2
87,Kit receptor signaling pathway WP304,0.3193026286109858,1.4531737773152966,1.6589663577674174,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.9999777920878447,0,0,4
88,DNA damage response WP707,0.32124951882873787,1.37358174792646,1.559753090397694,"['CCND1', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.9999777920878447,0,0,5
89,CAMKK2  Pathway WP4874,0.3347718826953628,1.5354298269706124,1.6802299590485779,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9999777920878447,0,0,3
90,G Protein Signaling Pathways WP35,0.3354665249046798,1.2996503496503498,1.419521135884466,"['GNG10', 'GNG3', 'RRAS', 'ADCY2', 'HRAS', 'CALM2']",0.9999777920878447,0,0,6
91,The alternative pathway of fetal androgen synthesis WP4524,0.3468405783096463,2.813819095477387,2.9795249951681386,['STAR'],0.9999777920878447,0,0,1
92,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3468405783096463,2.813819095477387,2.9795249951681386,['MAP1LC3A'],0.9999777920878447,0,0,1
93,Iron metabolism in placenta WP2007,0.3468405783096463,2.813819095477387,2.9795249951681386,['FTH1'],0.9999777920878447,0,0,1
94,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3468405783096463,2.813819095477387,2.9795249951681386,['MOCS2'],0.9999777920878447,0,0,1
95,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3496442833375842,1.7319300417891967,1.8199795892563906,"['GOT1', 'SCO2']",0.9999777920878447,0,0,2
96,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3496442833375842,1.7319300417891967,1.8199795892563906,"['LDHA', 'PDHA1']",0.9999777920878447,0,0,2
97,Acute viral myocarditis WP4298,0.35446957451009636,1.3094595545960153,1.3580834061319245,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9999777920878447,0,0,5
98,miRNA regulation of DNA damage response WP1530,0.35446957451009636,1.3094595545960153,1.3580834061319245,"['CCND1', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.9999777920878447,0,0,5
99,Modulators of TCR signaling and T cell activation WP5072,0.37660370676299054,1.3245967741935485,1.2935506367073726,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999777920878447,0,0,4
100,IL-7 signaling pathway WP205,0.38001191832335884,1.6080770336303536,1.5558992157876579,"['CCND1', 'BAD']",0.9999777920878447,0,0,2
101,Pancreatic adenocarcinoma pathway WP4263,0.38029756651608126,1.2284297520661156,1.1876474357081346,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'PAK4']",0.9999777920878447,0,0,6
102,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.38074962851260624,1.4072255790533736,1.3588356829980333,"['YWHAQ', 'ACTG1', 'PAK4']",0.9999777920878447,0,0,3
103,Oxidative Damage WP3941,0.38074962851260624,1.4072255790533736,1.3588356829980333,"['BAD', 'GADD45A', 'CYCS']",0.9999777920878447,0,0,3
104,Leptin signaling pathway WP2034,0.387819812940396,1.2510371117838324,1.1850004258445677,"['CCND1', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999777920878447,0,0,5
105,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3956552098755819,1.2866359447004607,1.192984453693022,"['RPS6', 'ADCY2', 'HRAS', 'MYL12B']",0.9999777920878447,0,0,4
106,Genotoxicity pathway WP4286,0.3956552098755819,1.2866359447004607,1.192984453693022,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9999777920878447,0,0,4
107,Alanine and aspartate metabolism WP106,0.4001902378700192,2.250854271356784,2.061366667817822,['GOT1'],0.9999777920878447,0,0,1
108,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4001902378700192,2.250854271356784,2.061366667817822,['DLL3'],0.9999777920878447,0,0,1
109,Thiamine metabolic pathways WP4297,0.4001902378700192,2.250854271356784,2.061366667817822,['PDHA1'],0.9999777920878447,0,0,1
110,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4001902378700192,2.250854271356784,2.061366667817822,['VIP'],0.9999777920878447,0,0,1
111,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4001902378700192,2.250854271356784,2.061366667817822,['RPS6'],0.9999777920878447,0,0,1
112,Insulin signaling in adipocytes (normal condition) WP3634,0.4001902378700192,2.250854271356784,2.061366667817822,['RPS6'],0.9999777920878447,0,0,1
113,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4001902378700192,2.250854271356784,2.061366667817822,['AHCY'],0.9999777920878447,0,0,1
114,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4001902378700192,2.250854271356784,2.061366667817822,['VEGFB'],0.9999777920878447,0,0,1
115,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4097612162914631,1.5007377598926894,1.3389292474786711,"['BAD', 'HRAS']",0.9999777920878447,0,0,2
116,16p11.2 proximal deletion syndrome WP4949,0.4210575421854977,1.1975867917641754,1.0358955390410942,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999777920878447,0,0,5
117,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4259906118138478,1.2987450615849407,1.1082684756358745,"['ADCY2', 'BANF1', 'HRAS']",0.9999777920878447,0,0,3
118,Imatinib and Chronic Myeloid Leukemia WP3640,0.4387907137189478,1.4068158953722334,1.1588402751800044,"['GADD45A', 'KIT']",0.9999777920878447,0,0,2
119,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.4491863394323632,1.8755443886097152,1.501030935202869,['HMGCS1'],0.9999777920878447,0,0,1
120,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4491863394323632,1.8755443886097152,1.501030935202869,['IDH3B'],0.9999777920878447,0,0,1
121,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4491863394323632,1.8755443886097152,1.501030935202869,['NSDHL'],0.9999777920878447,0,0,1
122,NOTCH1 regulation of endothelial cell calcification WP3413,0.4491863394323632,1.8755443886097152,1.501030935202869,['DLL3'],0.9999777920878447,0,0,1
123,Purine metabolism WP4792,0.4491863394323632,1.8755443886097152,1.501030935202869,['APRT'],0.9999777920878447,0,0,1
124,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4520805166023778,1.1847410865874364,0.940560002352608,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9999777920878447,0,0,4
125,Ras signaling WP4223,0.4548766857103415,1.0823646434701202,0.85260992859538,"['GNG10', 'GNG3', 'RRAS', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'PAK4']",0.9999777920878447,0,0,10
126,Glycosylation and related congenital defects WP4521,0.4670196027064678,1.323943661971831,1.008029582527762,"['DPM2', 'DPM3']",0.9999777920878447,0,0,2
127,Cell cycle WP179,0.46879192988955265,1.0942169419166385,0.8289746576456686,"['CDKN2D', 'CCND1', 'YWHAQ', 'GADD45A', 'RBX1', 'ANAPC11', 'YWHAH']",0.9999777920878447,0,0,7
128,Senescence and Autophagy in Cancer WP615,0.46958836774924856,1.107004470938897,0.8367833305052005,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9999777920878447,0,0,6
129,Pathways in clear cell renal cell carcinoma WP4018,0.46958836774924856,1.107004470938897,0.8367833305052005,"['SETD2', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.9999777920878447,0,0,6
130,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4705256940099936,1.1542597187758479,0.8702018402072449,"['PSMD8', 'PSMC5', 'PSMD7', 'STUB1']",0.9999777920878447,0,0,4
131,IL-3 signaling pathway WP286,0.49145433035468267,1.1640795916241276,0.8269461504910696,"['YWHAQ', 'BAD', 'HRAS']",0.9999777920878447,0,0,3
132,Serotonin and anxiety-related events WP3944,0.49418382317157844,1.6074659009332377,1.133018674169099,['CRH'],0.9999777920878447,0,0,1
133,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.49418382317157844,1.6074659009332377,1.133018674169099,['PDHA1'],0.9999777920878447,0,0,1
134,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.49418382317157844,1.6074659009332377,1.133018674169099,['CCK'],0.9999777920878447,0,0,1
135,Dopamine metabolism WP2436,0.49418382317157844,1.6074659009332377,1.133018674169099,['SOD1'],0.9999777920878447,0,0,1
136,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4943850402554793,1.2502794545048066,0.880747648707117,"['MAP1LC3A', 'FTL']",0.9999777920878447,0,0,2
137,SARS-CoV-2 mitochondrial interactions WP5038,0.4943850402554793,1.2502794545048066,0.880747648707117,"['NDUFB9', 'PHB']",0.9999777920878447,0,0,2
138,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5124541827762141,1.125176233635448,0.7522297877899046,"['BEX3', 'SERBP1', 'RNF7']",0.9999777920878447,0,0,3
139,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5124541827762141,1.125176233635448,0.7522297877899046,"['RRAS', 'CHP1', 'CALM2']",0.9999777920878447,0,0,3
140,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5208397580601218,1.1843693741395742,0.7725793626560982,"['RAB3A', 'NEFL']",0.9999777920878447,0,0,2
141,MAPK Cascade WP422,0.5208397580601218,1.1843693741395742,0.7725793626560982,"['RRAS', 'HRAS']",0.9999777920878447,0,0,2
142,Oxidative Stress WP408,0.5208397580601218,1.1843693741395742,0.7725793626560982,"['TXN2', 'SOD1']",0.9999777920878447,0,0,2
143,Parkinson's disease pathway WP2371,0.5208397580601218,1.1843693741395742,0.7725793626560982,"['CYCS', 'PARK7']",0.9999777920878447,0,0,2
144,Cytosolic DNA-sensing pathway WP4655,0.5329842543018102,1.0887827697105545,0.6851311441545712,"['POLR3K', 'POLR2K', 'POLR2L']",0.9999777920878447,0,0,3
145,Biomarkers for urea cycle disorders WP4583,0.5355087183727172,1.4064070351758795,0.87835478941564,['GOT1'],0.9999777920878447,0,0,1
146,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5355087183727172,1.4064070351758795,0.87835478941564,['CCND1'],0.9999777920878447,0,0,1
147,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5355087183727172,1.4064070351758795,0.87835478941564,['ADCY2'],0.9999777920878447,0,0,1
148,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5355087183727172,1.4064070351758795,0.87835478941564,['BAX'],0.9999777920878447,0,0,1
149,Nanoparticle triggered autophagic cell death WP2509,0.5355087183727172,1.4064070351758795,0.87835478941564,['MAP1LC3A'],0.9999777920878447,0,0,1
150,Nanoparticle triggered regulated necrosis WP2513,0.5355087183727172,1.4064070351758795,0.87835478941564,['FTL'],0.9999777920878447,0,0,1
151,Rett syndrome causing genes WP4312,0.5463499427384202,1.1250503018108653,0.6800879434672287,"['EIF2B2', 'GPS2']",0.9999777920878447,0,0,2
152,Integrated breast cancer pathway WP1984,0.5478102645406272,1.0095019574291566,0.6075448123123538,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9999777920878447,0,0,7
153,Notch Signaling Pathway Netpath WP61,0.5530168949125354,1.0546638972809668,0.6247478004402389,"['PSENEN', 'CCND1', 'DLL3']",0.9999777920878447,0,0,3
154,G1 to S cell cycle control WP45,0.5587154317410568,1.0226356304985338,0.5952915421934586,"['CDKN2D', 'CCND1', 'GADD45A', 'RPA2']",0.9999777920878447,0,0,4
155,Vitamin D-sensitive calcium signaling in depression WP4698,0.5708933575314279,1.0713806649420332,0.6005654864131648,"['GPX4', 'PVALB']",0.9999777920878447,0,0,2
156,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5708933575314279,1.0713806649420332,0.6005654864131648,"['MAP1LC3A', 'EIF2B2']",0.9999777920878447,0,0,2
157,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5708933575314279,1.0713806649420332,0.6005654864131648,"['CYCS', 'ACTG1']",0.9999777920878447,0,0,2
158,IL-2 signaling pathway WP49,0.5708933575314279,1.0713806649420332,0.6005654864131648,"['RPS6', 'HRAS']",0.9999777920878447,0,0,2
159,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5725291708086129,1.022612835301657,0.5703025795814599,"['IDI1', 'SQLE', 'HMGCS1']",0.9999777920878447,0,0,3
160,Exercise-induced Circadian Regulation WP410,0.5725291708086129,1.022612835301657,0.5703025795814599,"['IDI1', 'SUMO1', 'STBD1']",0.9999777920878447,0,0,3
161,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5734604959009733,1.2500279173646007,0.6950983079780405,['STAR'],0.9999777920878447,0,0,1
162,ERK Pathway in Huntington's Disease WP3853,0.5734604959009733,1.2500279173646007,0.6950983079780405,['HRAS'],0.9999777920878447,0,0,1
163,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5734604959009733,1.2500279173646007,0.6950983079780405,['CCND1'],0.9999777920878447,0,0,1
164,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5734604959009733,1.2500279173646007,0.6950983079780405,['RRAS'],0.9999777920878447,0,0,1
165,Osteoclast Signaling WP12,0.5734604959009733,1.2500279173646007,0.6950983079780405,['ATP6V1G1'],0.9999777920878447,0,0,1
166,PPAR-alpha pathway WP2878,0.5734604959009733,1.2500279173646007,0.6950983079780405,['CCND1'],0.9999777920878447,0,0,1
167,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5734604959009733,1.2500279173646007,0.6950983079780405,['ANAPC11'],0.9999777920878447,0,0,1
168,22q11.2 copy number variation syndrome WP4657,0.59316569291032,0.9695013744389157,0.5063526362869754,"['RANBP1', 'MRPL40', 'RAN', 'RBX1', 'PAK4']",0.9999777920878447,0,0,5
169,Aryl Hydrocarbon Receptor Pathway WP2873,0.5944576805381702,1.0225900859703676,0.5318549839643972,"['AIP', 'BAX']",0.9999777920878447,0,0,2
170,Glycogen Synthesis and Degradation WP500,0.5944576805381702,1.0225900859703676,0.5318549839643972,"['CALM3', 'CALM2']",0.9999777920878447,0,0,2
171,miRNA regulation of prostate cancer signaling pathways WP3981,0.5944576805381702,1.0225900859703676,0.5318549839643972,"['CCND1', 'BAD']",0.9999777920878447,0,0,2
172,p38 MAPK Signaling Pathway WP400,0.5944576805381702,1.0225900859703676,0.5318549839643972,"['DDIT3', 'HRAS']",0.9999777920878447,0,0,2
173,PDGF Pathway WP2526,0.5944576805381702,1.0225900859703676,0.5318549839643972,"['ARFIP2', 'HRAS']",0.9999777920878447,0,0,2
174,Transcriptional cascade regulating adipogenesis WP4211,0.608314229869473,1.1249246231155778,0.5591592011027091,['DDIT3'],0.9999777920878447,0,0,1
175,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.608314229869473,1.1249246231155778,0.5591592011027091,['CCND1'],0.9999777920878447,0,0,1
176,Genes targeted by miRNAs in adipocytes WP1992,0.608314229869473,1.1249246231155778,0.5591592011027091,['TMSB4X'],0.9999777920878447,0,0,1
177,Hedgehog Signaling Pathway Netpath WP47,0.608314229869473,1.1249246231155778,0.5591592011027091,['SAP18'],0.9999777920878447,0,0,1
178,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.608314229869473,1.1249246231155778,0.5591592011027091,['CCND1'],0.9999777920878447,0,0,1
179,Overview of nanoparticle effects WP3287,0.608314229869473,1.1249246231155778,0.5591592011027091,['BAX'],0.9999777920878447,0,0,1
180,Purine metabolism and related disorders WP4224,0.608314229869473,1.1249246231155778,0.5591592011027091,['APRT'],0.9999777920878447,0,0,1
181,Prader-Willi and Angelman Syndrome WP3998,0.6099224030077529,0.9640051791109193,0.47662685139352806,"['POMC', 'CCND1', 'FEZ1']",0.9999777920878447,0,0,3
182,Endothelin Pathways WP2197,0.6170390368652251,0.9780421660397166,0.47222124124454956,"['RIIAD1', 'CALM2']",0.9999777920878447,0,0,2
183,Histone Modifications WP2369,0.6170390368652251,0.9780421660397166,0.47222124124454956,"['SETD2', 'SET']",0.9999777920878447,0,0,2
184,Hippo-Merlin Signaling Dysregulation WP4541,0.6209525049568472,0.936952861952862,0.446458677276862,"['CCND1', 'KIT', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9999777920878447,0,0,6
185,Small cell lung cancer WP4658,0.6213447218917648,0.9370164816683485,0.44589732413588323,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'CKS1B']",0.9999777920878447,0,0,5
186,Thermogenesis WP4321,0.6231813038037423,0.9370799731182796,0.44316178543350415,"['RPS6', 'ADCY2', 'HRAS', 'ACTG1']",0.9999777920878447,0,0,4
187,ErbB signaling pathway WP673,0.6231813038037423,0.9370799731182796,0.44316178543350415,"['CCND1', 'BAD', 'HRAS', 'PAK4']",0.9999777920878447,0,0,4
188,Folate Metabolism WP176,0.6277779886772075,0.9371433366901645,0.4363046014452824,"['AHCY', 'GPX4', 'SOD1']",0.9999777920878447,0,0,3
189,p53 transcriptional gene network WP4963,0.6277779886772075,0.9371433366901645,0.4363046014452824,"['SIVA1', 'GADD45A', 'BAX']",0.9999777920878447,0,0,3
190,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6383337067907063,0.9178736010533246,0.4120280266051849,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9999777920878447,0,0,4
191,Common Pathways Underlying Drug Addiction WP2636,0.638640703913742,0.937206572769953,0.42025585593670667,"['CALM2', 'ACTG1']",0.9999777920878447,0,0,2
192,Apoptosis Modulation by HSP70 WP384,0.6403225829861595,1.0225673823663772,0.4558433534806218,['CYCS'],0.9999777920878447,0,0,1
193,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6403225829861595,1.0225673823663772,0.4558433534806218,['CCND1'],0.9999777920878447,0,0,1
194,Glutathione metabolism WP100,0.6403225829861595,1.0225673823663772,0.4558433534806218,['GPX4'],0.9999777920878447,0,0,1
195,Glycerolipids and Glycerophospholipids WP4722,0.6403225829861595,1.0225673823663772,0.4558433534806218,['CDIPT'],0.9999777920878447,0,0,1
196,Glycerophospholipid Biosynthetic Pathway WP2533,0.6403225829861595,1.0225673823663772,0.4558433534806218,['CDIPT'],0.9999777920878447,0,0,1
197,Pathogenic Escherichia coli infection WP2272,0.6450618152050009,0.9117334857516126,0.39971228359766603,"['YWHAQ', 'ARPC5L', 'ACTG1']",0.9999777920878447,0,0,3
198,Retinoblastoma gene in cancer WP2446,0.6530834588158617,0.8994354838709677,0.3832048023266899,"['RFC3', 'CCND1', 'H2AFZ', 'RPA2']",0.9999777920878447,0,0,4
199,Calcium Regulation in the Cardiac Cell WP536,0.6544506005309174,0.9081912239806976,0.3850360003657044,"['PKIB', 'GNG3', 'YWHAQ', 'CALM3', 'ADCY2', 'CALR', 'CALM2', 'YWHAH']",0.9999777920878447,0,0,8
200,Cardiac Progenitor Differentiation WP2406,0.6592719713519792,0.8996378269617706,0.37480632563909233,"['MESP1', 'KIT']",0.9999777920878447,0,0,2
201,Interleukin-11 Signaling Pathway WP2332,0.6592719713519792,0.8996378269617706,0.37480632563909233,"['RPS6', 'HRAS']",0.9999777920878447,0,0,2
202,TGF-beta Signaling Pathway WP366,0.6694836551850509,0.8873205741626794,0.3560360739044906,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'RBX1']",0.9999777920878447,0,0,6
203,Airway smooth muscle cell contraction WP4962,0.6697176310618158,0.9372696817420435,0.37575057337378837,['CALM2'],0.9999777920878447,0,0,1
204,miRNAs involved in DNA damage response WP1545,0.6697176310618158,0.9372696817420435,0.37575057337378837,['CCND1'],0.9999777920878447,0,0,1
205,MTHFR deficiency WP4288,0.6697176310618158,0.9372696817420435,0.37575057337378837,['CYCS'],0.9999777920878447,0,0,1
206,Nicotine Activity on Dopaminergic Neurons WP1602,0.6697176310618158,0.9372696817420435,0.37575057337378837,['ADCY2'],0.9999777920878447,0,0,1
207,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.68788326513336,0.8739579822491855,0.3269792557022877,"['YWHAQ', 'TAC1', 'ALDOA', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9999777920878447,0,0,7
208,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6967125387287396,0.8650947042906841,0.3126299829836717,['HRAS'],0.9999777920878447,0,0,1
209,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6967125387287396,0.8650947042906841,0.3126299829836717,['CALM2'],0.9999777920878447,0,0,1
210,Hippo-Yap signaling pathway WP4537,0.6967125387287396,0.8650947042906841,0.3126299829836717,['YWHAQ'],0.9999777920878447,0,0,1
211,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6967125387287396,0.8650947042906841,0.3126299829836717,['BAX'],0.9999777920878447,0,0,1
212,Aryl Hydrocarbon Receptor Netpath WP2586,0.6976846405312146,0.8328489455250019,0.2998156950871436,"['AIP', 'HRAS']",0.9999777920878447,0,0,2
213,IL-6 signaling pathway WP364,0.6976846405312146,0.8328489455250019,0.2998156950871436,"['BAD', 'VIP']",0.9999777920878447,0,0,2
214,Integrated Cancer Pathway WP1971,0.6976846405312146,0.8328489455250019,0.2998156950871436,"['BAD', 'BAX']",0.9999777920878447,0,0,2
215,Amino Acid metabolism WP3925,0.7084316333732488,0.8224891312357232,0.28351341771930594,"['LDHA', 'PDHA1', 'GOT1']",0.9999777920878447,0,0,3
216,Apoptosis Modulation and Signaling WP1772,0.7102665978716707,0.8385921050649878,0.28689484533085646,"['ENDOG', 'AIFM2', 'BAD', 'CYCS', 'BAX']",0.9999777920878447,0,0,5
217,Circadian rhythm related genes WP3594,0.7136084946288309,0.8558318874108348,0.2887754748771896,"['KDM5A', 'AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'HCRTR1']",0.9999777920878447,0,0,8
218,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7138779273922872,0.8426515151515152,0.2840100485107732,"['RAB3A', 'BAD', 'RPS6', 'RACK1', 'EIF2S1', 'HRAS']",0.9999777920878447,0,0,6
219,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7155062700175688,0.8030324805978729,0.2688271016327359,"['STAR', 'HRAS']",0.9999777920878447,0,0,2
220,One-carbon metabolism and related pathways WP3940,0.7155062700175688,0.8030324805978729,0.2688271016327359,"['GPX4', 'SOD1']",0.9999777920878447,0,0,2
221,TNF-alpha signaling pathway WP231,0.7206600183053714,0.8173020527859237,0.26773817714689874,"['BAD', 'BAX', 'TXN', 'HRAS']",0.9999777920878447,0,0,4
222,Blood Clotting Cascade WP272,0.7215030991458025,0.8032304379038048,0.2621893593208998,['F8A1'],0.9999777920878447,0,0,1
223,Fatty acid beta-oxidation WP143,0.7215030991458025,0.8032304379038048,0.2621893593208998,['TPI1'],0.9999777920878447,0,0,1
224,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7215030991458025,0.8032304379038048,0.2621893593208998,['H2AFZ'],0.9999777920878447,0,0,1
225,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7215030991458025,0.8032304379038048,0.2621893593208998,['RPS6'],0.9999777920878447,0,0,1
226,DNA damage response (only ATM dependent) WP710,0.7216843228688157,0.8261856710393541,0.26947488316947854,"['CCND1', 'BAD', 'RAC3', 'BAX', 'HRAS']",0.9999777920878447,0,0,5
227,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7324365158462518,0.7752723235967529,0.24140321820886756,"['CCND1', 'BAX']",0.9999777920878447,0,0,2
228,PPAR signaling pathway WP3942,0.7324365158462518,0.7752723235967529,0.24140321820886756,"['FABP3', 'FABP6']",0.9999777920878447,0,0,2
229,Gastrin signaling pathway WP4659,0.7435445868857232,0.8024362116188554,0.2377831509490314,"['CCND1', 'BAD', 'RPS6', 'KIT', 'HRAS']",0.9999777920878447,0,0,5
230,Statin inhibition of cholesterol production WP430,0.744269148215074,0.7496147403685092,0.22140062599563007,['SQLE'],0.9999777920878447,0,0,1
231,Urea cycle and associated pathways WP4595,0.744269148215074,0.7496147403685092,0.22140062599563007,['GOT1'],0.9999777920878447,0,0,1
232,NRF2-ARE regulation WP4357,0.744269148215074,0.7496147403685092,0.22140062599563007,['RBX1'],0.9999777920878447,0,0,1
233,PDGFR-beta pathway WP3972,0.744269148215074,0.7496147403685092,0.22140062599563007,['HRAS'],0.9999777920878447,0,0,1
234,Physiological and pathological hypertrophy of the heart WP1528,0.744269148215074,0.7496147403685092,0.22140062599563007,['CALM2'],0.9999777920878447,0,0,1
235,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.744269148215074,0.7496147403685092,0.22140062599563007,['BAX'],0.9999777920878447,0,0,1
236,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7485019742941226,0.7493628437290409,0.2170765057493686,"['NDUFA13', 'COPS6']",0.9999777920878447,0,0,2
237,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.749985967364828,0.7662043394671794,0.2204375882548645,"['BAD', 'BAX', 'HRAS']",0.9999777920878447,0,0,3
238,Regulation of Actin Cytoskeleton WP51,0.7539958771294628,0.8022366522366522,0.22652626305617393,"['RRAS', 'TMSB4X', 'BRK1', 'RAC3', 'ACTG1', 'PAK4']",0.9999777920878447,0,0,6
239,Interferon type I signaling pathways WP585,0.7637308431890191,0.7251249432076329,0.19545006942300974,"['RPS6', 'RACK1']",0.9999777920878447,0,0,2
240,Striated Muscle Contraction Pathway WP383,0.7651758639263637,0.7027010050251257,0.18807763173476671,['ACTG1'],0.9999777920878447,0,0,1
241,Autophagy WP4923,0.7651758639263637,0.7027010050251257,0.18807763173476671,['MAP1LC3B'],0.9999777920878447,0,0,1
242,Nanoparticle-mediated activation of receptor signaling WP2643,0.7651758639263637,0.7027010050251257,0.18807763173476671,['HRAS'],0.9999777920878447,0,0,1
243,Pregnane X receptor pathway WP2876,0.7651758639263637,0.7027010050251257,0.18807763173476671,['PSMC5'],0.9999777920878447,0,0,1
244,Integrin-mediated Cell Adhesion WP185,0.777976039522245,0.7488575268817205,0.18800783581526578,"['RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9999777920878447,0,0,4
245,Ethanol effects on histone modifications WP3996,0.7843749601363482,0.6613065326633166,0.1606102660548616,['AHCY'],0.9999777920878447,0,0,1
246,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7843749601363482,0.6613065326633166,0.1606102660548616,['HRAS'],0.9999777920878447,0,0,1
247,Head and Neck Squamous Cell Carcinoma WP4674,0.7866529455636934,0.7171048402648326,0.17208229452599558,"['CCND1', 'RPS6', 'HRAS']",0.9999777920878447,0,0,3
248,Complement system WP2806,0.7981344869956697,0.7245707596253902,0.16337488577277348,"['RPS19', 'CD59', 'TXN', 'CALR']",0.9999777920878447,0,0,4
249,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8020057827815025,0.6245114461194863,0.1377918686670766,['HRAS'],0.9999777920878447,0,0,1
250,Trans-sulfuration and one-carbon metabolism WP2525,0.8020057827815025,0.6245114461194863,0.1377918686670766,['AHCY'],0.9999777920878447,0,0,1
251,One-carbon metabolism WP241,0.8020057827815025,0.6245114461194863,0.1377918686670766,['AHCY'],0.9999777920878447,0,0,1
252,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8181963175667809,0.5915895265802698,0.11870419798353157,['SUPT4H1'],0.9999777920878447,0,0,1
253,Lipid Metabolism Pathway WP3965,0.8181963175667809,0.5915895265802698,0.11870419798353157,['PDHA1'],0.9999777920878447,0,0,1
254,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8181963175667809,0.5915895265802698,0.11870419798353157,['OMG'],0.9999777920878447,0,0,1
255,3q29 copy number variation syndrome WP4906,0.8283750318115365,0.6241336910350995,0.11751768965706048,"['NCBP2', 'DYNLL1']",0.9999777920878447,0,0,2
256,Breast cancer pathway WP4262,0.8288778527856907,0.7240143369175627,0.13588480452919824,"['CCND1', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'DLL3']",0.9999777920878447,0,0,6
257,Target Of Rapamycin (TOR) Signaling WP1471,0.8330641147560066,0.5619597989949748,0.10263896276147944,['IDI1'],0.9999777920878447,0,0,1
258,The influence of laminopathies on Wnt signaling WP4844,0.8330641147560066,0.5619597989949748,0.10263896276147944,['CCND1'],0.9999777920878447,0,0,1
259,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8330641147560066,0.5619597989949748,0.10263896276147944,['PPIB'],0.9999777920878447,0,0,1
260,Fluoropyrimidine Activity WP1601,0.8330641147560066,0.5619597989949748,0.10263896276147944,['GGH'],0.9999777920878447,0,0,1
261,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8330641147560066,0.5619597989949748,0.10263896276147944,['DDIT3'],0.9999777920878447,0,0,1
262,Melatonin metabolism and effects WP3298,0.8330641147560066,0.5619597989949748,0.10263896276147944,['CALM2'],0.9999777920878447,0,0,1
263,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8330641147560066,0.5619597989949748,0.10263896276147944,['CCND1'],0.9999777920878447,0,0,1
264,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8330641147560066,0.5619597989949748,0.10263896276147944,['BAX'],0.9999777920878447,0,0,1
265,Corticotropin-releasing hormone signaling pathway WP2355,0.8377844068989962,0.6478619567743434,0.11466799183776619,"['POMC', 'STAR', 'CRH']",0.9999777920878447,0,0,3
266,Pathways affected in adenoid cystic carcinoma WP3651,0.8392180933296827,0.6072108325629453,0.10643474550040634,"['SETD2', 'HRAS']",0.9999777920878447,0,0,2
267,Prolactin Signaling Pathway WP2037,0.846638868647009,0.6355811434760303,0.10581221007747975,"['RPS6', 'PPIB', 'HRAS']",0.9999777920878447,0,0,3
268,BDNF-TrkB Signaling WP3676,0.846717139730649,0.5351519502273271,0.08904318140920023,['HRAS'],0.9999777920878447,0,0,1
269,White fat cell differentiation WP4149,0.846717139730649,0.5351519502273271,0.08904318140920023,['DDIT3'],0.9999777920878447,0,0,1
270,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.846717139730649,0.5351519502273271,0.08904318140920023,['HRAS'],0.9999777920878447,0,0,1
271,Prion disease pathway WP3995,0.846717139730649,0.5351519502273271,0.08904318140920023,['HSP90B1'],0.9999777920878447,0,0,1
272,Focal Adhesion WP306,0.8486378756416139,0.7294032454494586,0.11971164032981983,"['CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9999777920878447,0,0,8
273,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8592545535654805,0.5107811786203746,0.07748042957328853,['CCND1'],0.9999777920878447,0,0,1
274,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8592545535654805,0.5107811786203746,0.07748042957328853,['CCND1'],0.9999777920878447,0,0,1
275,Hepatitis B infection WP4666,0.8620104422257904,0.6678559415693623,0.09916852255340212,"['YWHAQ', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9999777920878447,0,0,5
276,Apoptosis WP254,0.8630938607915677,0.6123592419664927,0.09015877350009935,"['BAD', 'CYCS', 'BAX']",0.9999777920878447,0,0,3
277,Endochondral Ossification with Skeletal Dysplasias WP4808,0.868118813008165,0.5615191146881288,0.07941379107792022,"['HMGCS1', 'CALM2']",0.9999777920878447,0,0,2
278,Endochondral Ossification WP474,0.868118813008165,0.5615191146881288,0.07941379107792022,"['HMGCS1', 'CALM2']",0.9999777920878447,0,0,2
279,Oncostatin M Signaling Pathway WP2374,0.868118813008165,0.5615191146881288,0.07941379107792022,"['RPS6', 'HRAS']",0.9999777920878447,0,0,2
280,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8707674303047791,0.4885296045444614,0.0676028988150698,['YWHAQ'],0.9999777920878447,0,0,1
281,ATM Signaling Pathway WP2516,0.88133941597359,0.4681323283082077,0.059130948366775585,['GADD45A'],0.9999777920878447,0,0,1
282,Heart Development WP1591,0.88133941597359,0.4681323283082077,0.059130948366775585,['VEGFB'],0.9999777920878447,0,0,1
283,IL-5 signaling pathway WP127,0.88133941597359,0.4681323283082077,0.059130948366775585,['RPS6'],0.9999777920878447,0,0,1
284,Differentiation Pathway WP2848,0.8910473338856598,0.44936683417085427,0.051837937240417055,['KIT'],0.9999777920878447,0,0,1
285,G13 Signaling Pathway WP524,0.8910473338856598,0.44936683417085427,0.051837937240417055,['CALM2'],0.9999777920878447,0,0,1
286,Hedgehog Signaling Pathway WP4249,0.8910473338856598,0.44936683417085427,0.051837937240417055,['CCND1'],0.9999777920878447,0,0,1
287,AGE/RAGE pathway WP2324,0.8921748368070047,0.5222029853539844,0.05957978887517456,"['CYCS', 'SOD1']",0.9999777920878447,0,0,2
288,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8921748368070047,0.5222029853539844,0.05957978887517456,"['IFI27L2', 'HRAS']",0.9999777920878447,0,0,2
289,Alpha 6 Beta 4 signaling pathway WP244,0.8999617404130642,0.43204483958252804,0.045538833984004254,['HRAS'],0.9999777920878447,0,0,1
290,Neural Crest Cell Migration during Development WP4564,0.8999617404130642,0.43204483958252804,0.045538833984004254,['PAK4'],0.9999777920878447,0,0,1
291,Regulation of Microtubule Cytoskeleton WP2038,0.8999617404130642,0.43204483958252804,0.045538833984004254,['PARD6A'],0.9999777920878447,0,0,1
292,DNA IR-damage and cellular response via ATR WP4016,0.9058758621863651,0.49890453834115805,0.049318210219503056,"['RPA2', 'EEF1E1']",0.9999777920878447,0,0,2
293,Phosphoinositides metabolism WP4971,0.9081474360495898,0.41600595570444815,0.04008156607163515,['PIP4P1'],0.9999777920878447,0,0,1
294,EGF/EGFR signaling pathway WP437,0.9108079807085104,0.6027364560615431,0.05630955794893771,"['NDUFA13', 'AP2S1', 'NEDD8', 'HRAS', 'AP2M1']",0.9999777920878447,0,0,5
295,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9156639343848392,0.4011127063890883,0.035340382153722746,['HRAS'],0.9999777920878447,0,0,1
296,Neovascularisation processes WP4331,0.9156639343848392,0.4011127063890883,0.035340382153722746,['KIT'],0.9999777920878447,0,0,1
297,Neural Crest Cell Migration in Cancer WP4565,0.9156639343848392,0.4011127063890883,0.035340382153722746,['PAK4'],0.9999777920878447,0,0,1
298,Insulin Signaling WP481,0.9193354685675611,0.5899410483828137,0.04961651208101726,"['XBP1', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9999777920878447,0,0,5
299,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9225658929624155,0.38724657771616705,0.031210709868213223,['CCND1'],0.9999777920878447,0,0,1
300,Microglia Pathogen Phagocytosis Pathway WP3937,0.9225658929624155,0.38724657771616705,0.031210709868213223,['RAC3'],0.9999777920878447,0,0,1
301,Glioblastoma signaling pathways WP2261,0.9285302198770162,0.45801338644109557,0.03396276972955678,"['CCND1', 'HRAS']",0.9999777920878447,0,0,2
302,Development of ureteric collection system WP5053,0.9289035092395778,0.37430485762144056,0.027605136995859182,['CCND1'],0.9999777920878447,0,0,1
303,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9289035092395778,0.37430485762144056,0.027605136995859182,['BAX'],0.9999777920878447,0,0,1
304,Notch Signaling WP268,0.9289035092395778,0.37430485762144056,0.027605136995859182,['DLL3'],0.9999777920878447,0,0,1
305,Prostaglandin Synthesis and Regulation WP98,0.9289035092395778,0.37430485762144056,0.027605136995859182,['S100A6'],0.9999777920878447,0,0,1
306,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9347228842682525,0.36219808721024477,0.024450244930229924,['RPS6'],0.9999777920878447,0,0,1
307,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9347228842682525,0.36219808721024477,0.024450244930229924,['RPS6'],0.9999777920878447,0,0,1
308,Vitamin B12 metabolism WP1533,0.9347228842682525,0.36219808721024477,0.024450244930229924,['SOD1'],0.9999777920878447,0,0,1
309,Wnt Signaling Pathway WP363,0.9347228842682525,0.36219808721024477,0.024450244930229924,['CCND1'],0.9999777920878447,0,0,1
310,Chemokine signaling pathway WP3929,0.9360893280427958,0.5337461597542242,0.035250929456071195,"['GNG10', 'GNG3', 'ADCY2', 'HRAS']",0.9999777920878447,0,0,4
311,Pre-implantation embryo WP3527,0.9400663565253741,0.35084798994974875,0.021684094817716385,['DDIT3'],0.9999777920878447,0,0,1
312,Phosphodiesterases in neuronal function WP4222,0.9449728087967759,0.340185777371707,0.019254217562019876,['ADCY2'],0.9999777920878447,0,0,1
313,Mesodermal commitment pathway WP2857,0.9490195370763332,0.5093016862170088,0.026649665828047918,"['EPB41L5', 'SETD2', 'CCND1', 'RPL38']",0.9999777920878447,0,0,4
314,NRF2 pathway WP2884,0.9518536387091663,0.5035338890902501,0.02484637464309133,"['FTH1', 'TXN', 'SLC6A20', 'FTL']",0.9999777920878447,0,0,4
315,TGF-beta Receptor Signaling WP560,0.9536145738417035,0.320689160086145,0.015231356081776937,['HRAS'],0.9999777920878447,0,0,1
316,Cardiac Hypertrophic Response WP2795,0.9536145738417035,0.320689160086145,0.015231356081776937,['CALM2'],0.9999777920878447,0,0,1
317,IL-4 signaling pathway WP395,0.9536145738417035,0.320689160086145,0.015231356081776937,['BAD'],0.9999777920878447,0,0,1
318,Netrin-UNC5B signaling pathway WP4747,0.9536145738417035,0.320689160086145,0.015231356081776937,['DAPK1'],0.9999777920878447,0,0,1
319,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9571440300514091,0.6141475157702339,0.02690051929748126,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS', 'HSP90B1']",0.9999777920878447,0,0,10
320,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.957412796918607,0.3117532104969291,0.013567697930102974,['PIN1'],0.9999777920878447,0,0,1
321,Endoderm differentiation WP2853,0.9617069852416047,0.44231992367626016,0.01727058659404672,"['EPB41L5', 'TCEAL2', 'NME1']",0.9999777920878447,0,0,3
322,Adipogenesis WP236,0.9640729982545652,0.4365362733942794,0.015972103939859907,"['GADD45A', 'DDIT3', 'GTF3A']",0.9999777920878447,0,0,3
323,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9641024125202863,0.2952922507273208,0.010795221153123891,['HRAS'],0.9999777920878447,0,0,1
324,Peptide GPCRs WP24,0.9670425293012113,0.2876948846798093,0.009641462233994718,['HCRTR1'],0.9999777920878447,0,0,1
325,Spinal Cord Injury WP2431,0.968397903653103,0.4254082374086963,0.013660802345249233,"['CCND1', 'GADD45A', 'OMG']",0.9999777920878447,0,0,3
326,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9697420471077026,0.2804773869346734,0.00861771642334069,['YWHAQ'],0.9999777920878447,0,0,1
327,Vitamin D Receptor Pathway WP2877,0.9715523085238534,0.45692067149440424,0.013186807599396628,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9999777920878447,0,0,4
328,Ectoderm Differentiation WP2858,0.9739733199228812,0.4097339915997347,0.010805245870930649,"['MAFB', 'KCNK10', 'LY6E']",0.9999777920878447,0,0,3
329,MECP2 and Associated Rett Syndrome WP3584,0.9744963620618089,0.26707346255084946,0.006899707545379891,['RPS6'],0.9999777920878447,0,0,1
330,PI3K-Akt signaling pathway WP4172,0.9797535879454928,0.5608162516436136,0.011471036449257467,"['GNG10', 'GNG3', 'CCND1', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'HSP90B1']",0.9999777920878447,0,0,10
331,Fragile X Syndrome  WP4549,0.9816286553871111,0.32947686116700203,0.006109223707558499,"['AP2S1', 'AP2M1']",0.9999777920878447,0,0,2
332,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9824472253502318,0.3815915957154628,0.006757472521905382,"['STRAP', 'HRAS', 'DLL3']",0.9999777920878447,0,0,3
333,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9859821108408308,0.2287765357399241,0.0032296538449388887,['ACTG1'],0.9999777920878447,0,0,1
334,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9871311261915565,0.22418090452261308,0.0029036796467010162,['CALM2'],0.9999777920878447,0,0,1
335,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9871311261915565,0.22418090452261308,0.0029036796467010162,['CCND1'],0.9999777920878447,0,0,1
336,Neural Crest Differentiation WP2064,0.9871311261915565,0.22418090452261308,0.0029036796467010162,['DLL3'],0.9999777920878447,0,0,1
337,T-cell receptor (TCR) signaling pathway WP69,0.9881860281097575,0.21976549413735344,0.002611761566789781,['HRAS'],0.9999777920878447,0,0,1
338,Ebola Virus Pathway on Host WP4217,0.9905562780557704,0.2907314013953853,0.0027586329962405094,"['EIF2S1', 'ACTG1']",0.9999777920878447,0,0,2
339,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9908599704868892,0.20750046528941002,0.0019052808633122124,['CCND1'],0.9999777920878447,0,0,1
340,Nuclear Receptors Meta-Pathway WP2882,0.9916369927462217,0.47960471899351353,0.004027803593253023,"['PSMC5', 'CCND1', 'FTH1', 'AIP', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9999777920878447,0,0,8
341,B Cell Receptor Signaling Pathway WP23,0.9945299244488123,0.1866499162479062,0.0010237918125885269,['HRAS'],0.9999777920878447,0,0,1
342,Metapathway biotransformation Phase I and II WP702,0.994818857948856,0.2631790744466801,0.001367112838712181,"['GPX4', 'GSTO1']",0.9999777920878447,0,0,2
343,Wnt signaling pathway and pluripotency WP399,0.9949785621413925,0.18357360573358597,0.0009241256200564392,['CCND1'],0.9999777920878447,0,0,1
344,Genes related to primary cilium development (based on CRISPR) WP4536,0.995390418833165,0.18059653104230833,0.0008343989640377037,['DYNLL1'],0.9999777920878447,0,0,1
345,Wnt signaling WP428,0.9969952111732419,0.16704417610440261,0.0005026880884993525,['CCND1'],0.9999777920878447,0,0,1
346,Pathways Regulating Hippo Signaling WP4540,0.9969952111732419,0.16704417610440261,0.0005026880884993525,['KIT'],0.9999777920878447,0,0,1
347,MAPK Signaling Pathway WP382,0.9975851623304022,0.3572860876089938,0.0008638313296883949,"['RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'HRAS']",0.9999777920878447,0,0,5
348,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9976756452394037,0.15984206748025845,0.00037196212411751107,['HRAS'],0.9999777920878447,0,0,1
349,ESC Pluripotency Pathways WP3931,0.9976756452394037,0.15984206748025845,0.00037196212411751107,['HRAS'],0.9999777920878447,0,0,1
350,Male infertility WP4673,0.9978663010270541,0.15757661547172483,0.00033658027091285265,['PEX10'],0.9999777920878447,0,0,1
351,Osteoblast differentiation WP4787,0.9978663010270541,0.15757661547172483,0.00033658027091285265,['DLL3'],0.9999777920878447,0,0,1
352,Regulation of toll-like receptor signaling pathway WP1449,0.9991673422813181,0.1363034685623238,0.00011354141231097712,['CUEDC2'],0.9999777920878447,0,0,1
353,"GPCRs, Class A Rhodopsin-like WP455",0.9997796097262,0.1768867171281658,3.8988408510311346e-05,"['GPR22', 'HCRTR1']",0.9999777920878447,0,0,2
354,Ciliopathies WP4803,0.9999777920878447,0.08835447076653107,1.9621901134688277e-06,['CCDC28B'],0.9999777920878447,0,0,1
